I volunteer my time and serve as director for the DBSA for many reasons. The three most important reasons to me are that I have seen the powerful therapeutic advocacy on patients and families that have been affected by mood disorders. Secondly, I am forever grateful for the privilege that patients and families have given me; not only an incredible purpose but also a tremendous inspiration. Thirdly, I really believe that DBSA plays a critical role in representing the voice of those affected at the level of policy, education, and research, as well as in the development of new treatments for mood disorders.
Roger is currently the head of the Mood Disorders Psychopharmacology Unit at the University Health Network and a Professor of Psychiatry and Pharmacology University of Toronto in Toronto, Canada. Dr. McIntyre is on the DBSA Board of Directors and also serves as the Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. Dr. McIntyre was named by Thomson Reuters in 2014-2019, inclusive, as one of “The World’s Most Influential Scientific Minds”. This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.
